Fortress Biotech (NASDAQ: FBIO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.280 | -0.100 | 0.1800 | ||||
REV | 23.925M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Fortress Biotech (NASDAQ: FBIO) through any online brokerage.
Other companies in Fortress Biotech’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Anixa Biosciences (NASDAQ:ANIX), Adverum Biotechnologies (NASDAQ:ADVM), Curis (NASDAQ:CRIS) and TCR2 Therapeutics (NASDAQ:TCRR).
The latest price target for Fortress Biotech (NASDAQ: FBIO) was reported by Roth Capital on Tuesday, April 20, 2021. The analyst firm set a price target for 5.00 expecting FBIO to rise to within 12 months (a possible 466.38% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Fortress Biotech (NASDAQ: FBIO) is $0.8828 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Fortress Biotech.
Fortress Biotech’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Fortress Biotech.
Fortress Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.